Imricor Medical Systems Inc Total Liabilities
Imricor Medical Systems Inc total liabilities. Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has total liabilities worth AU$34.26 Million AUD (≈ $24.24 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Imricor Medical Systems Inc to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Imricor Medical Systems Inc (2016–2025)
Total liabilities of Imricor Medical Systems Inc from 2016 to 2025. This chart illustrates how Imricor Medical Systems Inc's total liabilities have evolved over time, based on quarterly financial data. Explore IMR long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Imricor Medical Systems Inc Competitors by Total Liabilities
The table below lists competitors of Imricor Medical Systems Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Yangfan New Materials Co Ltd
SHE:300637
|
China | CN¥656.73 Million |
|
Goody Science & Technology Co Ltd
SHE:002694
|
China | CN¥1.12 Billion |
|
Immobiliere Dassault SA
PA:IMDA
|
France | €487.75 Million |
|
Ace Hardware Indonesia Tbk
JK:ACES
|
Indonesia | Rp2.28 Trillion |
|
Advanced Enzyme Technologies Limited
NSE:ADVENZYMES
|
India | Rs-16.83 Billion |
|
IndoStar Capital Finance Limited
NSE:INDOSTAR
|
India | Rs-37.83 Billion |
|
Zhejiang Tailin Bioengineering Co Ltd
SHE:300813
|
China | CN¥140.46 Million |
|
Hangzhou Prevail Optoelectronic Equipment Co Ltd
SHE:300710
|
China | CN¥101.07 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Imricor Medical Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see IMR asset base.
Liquidity & Leverage Metrics
Imricor Medical Systems Inc Total Liabilities Ratios Explained
Imricor Medical Systems Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Imricor Medical Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Imricor Medical Systems Inc (2016–2025)
The table below shows the annual total liabilities of Imricor Medical Systems Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | AU$34.26 Million ≈ $24.24 Million |
+18.12% |
| 2024-12-31 | AU$29.00 Million ≈ $20.52 Million |
+69.98% |
| 2023-12-31 | AU$17.06 Million ≈ $12.07 Million |
+175.61% |
| 2022-12-31 | AU$6.19 Million ≈ $4.38 Million |
+38.68% |
| 2021-12-31 | AU$4.46 Million ≈ $3.16 Million |
-6.09% |
| 2020-12-31 | AU$4.75 Million ≈ $3.36 Million |
+36.27% |
| 2019-12-31 | AU$3.49 Million ≈ $2.47 Million |
+34.78% |
| 2018-12-31 | AU$2.59 Million ≈ $1.83 Million |
-68.63% |
| 2017-12-31 | AU$8.25 Million ≈ $5.84 Million |
+10.08% |
| 2016-12-31 | AU$7.50 Million ≈ $5.30 Million |
-- |
About Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more